- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
Market Overview
The Glucagon Like Peptide-1 (GLP-1) Agonists market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Glucagon Like Peptide-1 (GLP-1) Agonists market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 12.7%% in the forecast period of 2020 to 2025 and will expected to reach USD 11310 million by 2025, from USD 7001.5 million in 2019.
Market segmentation
Glucagon Like Peptide-1 (GLP-1) Agonists market is split by Type and Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Breakdown by Type, Glucagon Like Peptide-1 (GLP-1) Agonists market has been segmented into Exenatied, Liraglutide, Lixisenatide, Albiglutide, Dulaglutide, etc.
Breakdown by Application, Glucagon Like Peptide-1 (GLP-1) Agonists has been segmented into Hospital, Pharmacy, Other, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Glucagon Like Peptide-1 (GLP-1) Agonists market presented in the report. This section sheds light on the sales growth of different regional and country-level Glucagon Like Peptide-1 (GLP-1) Agonists markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Glucagon Like Peptide-1 (GLP-1) Agonists market.
For United States, this report analyses the United States market by players, Type and Application, for the period 2015-2025.
Competitive Landscape and Glucagon Like Peptide-1 (GLP-1) Agonists Market Share Analysis
Glucagon Like Peptide-1 (GLP-1) Agonists competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Glucagon Like Peptide-1 (GLP-1) Agonists sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Glucagon Like Peptide-1 (GLP-1) Agonists sales, revenue and market share for each player covered in this report.
The major players covered in Glucagon Like Peptide-1 (GLP-1) Agonists are: Novo Nordisk, GSK, AstraZeneca, Amylin, Eli Lilly, Bristol-Myers Squibb, Sanofi, etc. Among other players domestic and global, Glucagon Like Peptide-1 (GLP-1) Agonists market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The key market players for global Glucagon Like Peptide-1 (GLP-1) Agonists market are listed below:
Novo Nordisk
GSK
AstraZeneca
Amylin
Eli Lilly
Bristol-Myers Squibb
Sanofi
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt and South Africa)
Market segment by Type, covers:
Exenatied
Liraglutide
Lixisenatide
Albiglutide
Dulaglutide
Market segment by Application, can be divided into
Hospital
Pharmacy
Other
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Glucagon Like Peptide-1 (GLP-1) Agonists Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Exenatied
1.2.3 Liraglutide
1.2.4 Lixisenatide
1.2.5 Albiglutide
1.2.6 Dulaglutide
1.3 Market Analysis by Application
1.3.1 Overview: Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Forecast (2015-2025)
1.4.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Forecast (2015-2025)
1.4.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Forecast (2015-2025)
1.5 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Overview by Geography (2015-2020)
2 Manufacturers Profiles
2.1 Novo Nordisk
2.1.1 Novo Nordisk Details
2.1.2 Novo Nordisk Major Business
2.1.3 Novo Nordisk SWOT Analysis
2.1.4 Novo Nordisk Product and Services
2.1.5 Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK SWOT Analysis
2.2.4 GSK Product and Services
2.2.5 GSK Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 AstraZeneca
2.3.1 AstraZeneca Details
2.3.2 AstraZeneca Major Business
2.3.3 AstraZeneca SWOT Analysis
2.3.4 AstraZeneca Product and Services
2.3.5 AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Amylin
2.4.1 Amylin Details
2.4.2 Amylin Major Business
2.4.3 Amylin SWOT Analysis
2.4.4 Amylin Product and Services
2.4.5 Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Eli Lilly
2.5.1 Eli Lilly Details
2.5.2 Eli Lilly Major Business
2.5.3 Eli Lilly SWOT Analysis
2.5.4 Eli Lilly Product and Services
2.5.5 Eli Lilly Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Bristol-Myers Squibb
2.6.1 Bristol-Myers Squibb Details
2.6.2 Bristol-Myers Squibb Major Business
2.6.3 Bristol-Myers Squibb Product and Services
2.6.4 Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Sanofi
2.7.1 Sanofi Details
2.7.2 Sanofi Major Business
2.7.3 Sanofi Product and Services
2.7.4 Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market, Company Landscape
3.1 Company Market Share Analysis: Global
3.1.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Market Share by Manufacturer (2018-2019)
3.1.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Market Share by Manufacturer (2018-2019)
3.2 Company Market Share Analysis: United States
3.2.1 Key Players Glucagon Like Peptide-1 (GLP-1) Agonists Sales in United States (2018-2019)
3.2.2 United States Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturer Market Share in 2019
3.3.2 Top 6 Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturer Market Share in 2019
4 Market Size by Geography
4.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Geography (2015-2020)
4.1.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Geography (2015-2020)
4.1.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Regions (2015-2020)
4.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Forecast by Regions (2020-2025)
4.2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Forecast by Regions (2020-2025)
4.2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Forecast by Regions (2020-2025)
4.3 North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Forecast (2015-2025)
4.4 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Forecast (2015-2025)
4.5 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Forecast (2015-2025)
4.6 South America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Forecast (2015-2025)
4.7 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Forecast (2015-2025)
5 North America by Country
5.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country (2015-2020)
5.1.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Market Share by Country (2015-2020)
5.1.2 North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Market Share by Country (2015-2020)
5.2 North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Forecast by Country (2020-2025)
5.2.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Forecast by Country (2020-2025)
5.2.2 North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Forecast by Country (2020-2025)
5.3 United States Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Forecast (2015-2025)
5.4 Canada Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Forecast (2015-2025)
5.5 Mexico Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Forecast (2015-2025)
6 Europe by Country
6.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country (2015-2020)
6.1.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2015-2020)
6.1.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2015-2020)
6.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Forecast by Country (2020-2025)
6.2.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Forecast by Country (2020-2025)
6.2.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Forecast by Country (2020-2025)
6.3 Germany Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Forecast (2015-2025)
6.4 United Kingdom Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Forecast (2015-2025)
6.5 France Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Forecast (2015-2025)
6.6 Russia Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Forecast (2015-2025)
6.7 Italy Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Forecast (2015-2025)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Region (2015-2020)
7.1.1 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Region (2015-2020)
7.1.2 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Region (2015-2020)
7.2 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Forecast by Region (2020-2025)
7.2.1 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Forecast by Region (2020-2025)
7.2.2 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Forecast by Region (2020-2025)
7.3 China Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Forecast (2015-2025)
7.4 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Forecast (2015-2025)
7.5 Korea Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Forecast (2015-2025)
7.6 India Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Forecast (2015-2025)
7.7 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Forecast (2015-2025)
7.8 Australia Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Forecast (2015-2025)
8 South America by Country
8.1 South America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country (2015-2020)
8.1.1 South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2015-2020)
8.1.2 South America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2015-2020)
8.2 South America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Forecast by Country (2020-2025)
8.2.1 South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Forecast by Country (2020-2025)
8.2.2 South America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Forecast by Country (2020-2025)
8.3 Brazil Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Forecast (2015-2025)
8.4 Argentina Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Forecast (2015-2025)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country (2015-2020)
9.1.1 Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2015-2020)
9.1.2 Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2015-2020)
9.2 Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Forecast by Country (2020-2025)
9.2.1 Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Forecast by Country (2020-2025)
9.2.2 Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Forecast by Country (2020-2025)
9.3 Saudi Arabia Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Forecast (2015-2025)
9.4 Turkey Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Forecast (2015-2025)
9.5 Egypt Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Forecast (2015-2025)
9.6 South Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Forecast (2015-2025)
10 Market Segment by Type
10.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Type (2015-2020)
10.1.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2015-2020)
10.1.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2015-2020)
10.1.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Type (2015-2020)
10.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Forecast by Type (2020-2025)
10.2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Forecast by Type (2020-2025)
10.2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Forecast by Type (2020-2025)
10.2.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Price and Forecast by Type (2020-2025)
10.3 United States Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Forecast by Type (2015-2025)
10.3.1 United States Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Type (2015-2020)
10.3.2 United States Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Forecast by Type (2020-2025)
11 Market Segment by Application
11.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Application (2015-2020)
11.1.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2015-2020)
11.1.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application (2015-2020)
11.1.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Application (2015-2020)
11.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Forecast by Application (2020-2025)
11.2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Forecast by Application (2020-2025)
11.2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Forecast by Application (2020-2025)
11.2.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Price and Forecast by Application (2020-2025)
11.3 United States Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Forecast by Application (2015-2025)
11.3.1 United States Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Application (2015-2020)
11.3.2 United States Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Forecast by Application (2020-2025)
12 Sales Channel, Distributors, Costumers, and Market Dynamics
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Distributors, Traders and Dealers
12.4.1 Market Opportunities
12.4.2 Market Risk
12.4.3 Market Driving Force
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
List of Tables
Table 1. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Glucagon Like Peptide-1 (GLP-1) Agonists by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Overview by Geography (2015-2020) (USD Million)
Table 5. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 7. Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Major Business
Table 8. Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Total Revenue (USD Million) (2018-2019)
Table 9. Novo Nordisk SWOT Analysis
Table 10. Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Product and Services
Table 11. Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 12. GSK Basic Information, Manufacturing Base and Competitors
Table 13. GSK Glucagon Like Peptide-1 (GLP-1) Agonists Major Business
Table 14. GSK Glucagon Like Peptide-1 (GLP-1) Agonists Total Revenue (USD Million) (2018-2019)
Table 15. GSK SWOT Analysis
Table 16. GSK Glucagon Like Peptide-1 (GLP-1) Agonists Product and Services
Table 17. GSK Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 18. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 19. AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Major Business
Table 20. AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Total Revenue (USD Million) (2018-2019)
Table 21. AstraZeneca SWOT Analysis
Table 22. AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Product and Services
Table 23. AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 24. Amylin Basic Information, Manufacturing Base and Competitors
Table 25. Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Major Business
Table 26. Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Total Revenue (USD Million) (2018-2019)
Table 27. Amylin SWOT Analysis
Table 28. Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Product and Services
Table 29. Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 30. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 31. Eli Lilly Glucagon Like Peptide-1 (GLP-1) Agonists Major Business
Table 32. Eli Lilly Glucagon Like Peptide-1 (GLP-1) Agonists Total Revenue (USD Million) (2018-2019)
Table 33. Eli Lilly SWOT Analysis
Table 34. Eli Lilly Glucagon Like Peptide-1 (GLP-1) Agonists Product and Services
Table 35. Eli Lilly Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 36. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 37. Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Major Business
Table 38. Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Total Revenue (USD Million) (2018-2019)
Table 39. Bristol-Myers Squibb SWOT Analysis
Table 40. Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Product and Services
Table 41. Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 42. Sanofi Basic Information, Manufacturing Base and Competitors
Table 43. Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Major Business
Table 44. Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Total Revenue (USD Million) (2018-2019)
Table 45. Sanofi SWOT Analysis
Table 46. Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Product and Services
Table 47. Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 48. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Manufacturer (2018-2019) (K Units)
Table 49. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Manufacturer (2018-2019) (USD Million)
Table 50. Key Players Glucagon Like Peptide-1 (GLP-1) Agonists Sales in United States (2018-2019) (K Units)
Table 51. Key Players Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in United States (2018-2019)
Table 52. Key Players Revenue of Glucagon Like Peptide-1 (GLP-1) Agonists in United States (2018-2019) (USD Million)
Table 53. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Regions (2015-2020) (K Units)
Table 54. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Regions (2015-2020)
Table 55. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Regions (2015-2020) (USD Million)
Table 56. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Forecast by Regions (2020-2025) (K Units)
Table 57. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Regions (2020-2025)
Table 58. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Forecast by Regions (2020-2025) (USD Million)
Table 59. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Regions (2020-2025) (USD Million)
Table 60. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Countries (2015-2020) (K Units)
Table 61. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Countries (2015-2020)
Table 62. North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Countries (2015-2020) (USD Million)
Table 63. North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Countries (2015-2020)
Table 64. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2020-2025) (K Units)
Table 65. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Country (2020-2025)
Table 66. North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2020-2025) (USD Million)
Table 67. North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Country (2020-2025)
Table 68. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Countries (2015-2020) (K Units)
Table 69. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Countries (2015-2020)
Table 70. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Countries (2015-2020) (USD Million)
Table 71. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Countries (2015-2020)
Table 72. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2020-2025) (K Units)
Table 73. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Country (2020-2025)
Table 74. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2020-2025) (USD Million)
Table 75. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Country (2020-2025)
Table 76. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Countries (2015-2020) (K Units)
Table 77. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Countries (2015-2020)
Table 78. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Countries (2015-2020)
Table 80. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2020-2025) (K Units)
Table 81. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Country (2020-2025)
Table 82. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2020-2025) (USD Million)
Table 83. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Country (2020-2025)
Table 84. South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Countries (2015-2020) (K Units)
Table 85. South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Countries (2015-2020)
Table 86. South America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Countries (2015-2020) (USD Million)
Table 87. South America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Countries (2015-2020)
Table 88. South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2020-2025) (K Units)
Table 89. South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Country (2020-2025)
Table 90. South America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2020-2025) (USD Million)
Table 91. South America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Country (2020-2025)
Table 92. Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Countries (2015-2020) (K Units)
Table 93. Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Countries (2015-2020)
Table 94. Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Countries (2015-2020) (USD Million)
Table 95. Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Countries (2015-2020)
Table 96. Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2020-2025) (K Units)
Table 97. Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Country (2020-2025)
Table 98. Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2020-2025) (USD Million)
Table 99. Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Country (2020-2025)
Table 100. United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2015-2020) (K Units)
Table 101. United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2015-2020)
Table 102. United States Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2015-2020) (USD Million)
Table 103. United States Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Type (2015-2020)
Table 104. United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2020-2025) (K Units)
Table 105. United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2020-2025)
Table 106. United States Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2020-2025) (USD Million)
Table 107. United States Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Type (2020-2025)
Table 108. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2015-2020) (K Units)
Table 109. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2015-2020)
Table 110. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application (2015-2020) (USD Million)
Table 111. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Application (2015-2020)
Table 112. Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Application (2015-2020) (USD/Unit)
Table 113. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2020-2025) (K Units)
Table 114. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2020-2025)
Table 115. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application (2020-2025) (USD Million)
Table 116. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Application (2020-2025)
Table 117. Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Application (2020-2025) (USD/Unit)
Table 118. United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2015-2020) (K Units)
Table 119. United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2015-2020)
Table 120. United States Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application (2015-2020) (USD Million)
Table 121. United States Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Application (2015-2020)
Table 122. United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2020-2025) (K Units)
Table 123. United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2020-2025)
Table 124. United States Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application (2020-2025) (USD Million)
Table 125. United States Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Application (2020-2025)
Table 126. Direct Channel Pros & Cons
Table 127. Indirect Channel Pros & Cons
Table 128. Distributors/Traders/ Dealers List
Table 129. Customers of Glucagon Like Peptide-1 (GLP-1) Agonists
Table 130. Market Opportunities in Next Few Years
Table 131. Market Risks Analysis
Table 132. Market Drivers
List of Figures
Figure 1. Glucagon Like Peptide-1 (GLP-1) Agonists Picture
Figure 2. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 3. Exenatied Picture
Figure 4. Liraglutide Picture
Figure 5. Lixisenatide Picture
Figure 6. Albiglutide Picture
Figure 7. Dulaglutide Picture
Figure 8. Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application in 2019
Figure 9. Hospital Picture
Figure 10. Pharmacy Picture
Figure 11. Other Picture
Figure 12. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Status and Outlook (2015-2025) (USD Million)
Figure 13. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Growth Rate (2015-2025) (K Units)
Figure 14. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Manufacturer in 2019
Figure 15. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Manufacturer in 2019
Figure 16. Key Players Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share in United States in 2019
Figure 17. Global Top 5 Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturer Market Share in 2019
Figure 18. Top 3 Glucagon Like Peptide-1 (GLP-1) Agonists Players Market Share in United States in 2019
Figure 19. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Regions in 2019
Figure 20. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales YoY Growth (2015-2025) (K Units)
Figure 21. North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue YoY Growth (2015-2025) (USD Million)
Figure 22. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales YoY Growth (2015-2020) (K Units)
Figure 23. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue YoY Growth (2015-2020) (USD Million)
Figure 24. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales YoY Growth (2015-2020) (K Units)
Figure 25. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Revenue YoY Growth (2015-2020) (USD Million)
Figure 26. South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales YoY Growth (2015-2020) (K Units)
Figure 27. South America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue YoY Growth (2015-2020) (USD Million)
Figure 28. Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales YoY Growth (2015-2020) (K Units)
Figure 29. Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue YoY Growth (2015-2020) (USD Million)
Figure 30. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Country in 2019
Figure 31. North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Country in 2019
Figure 32. United States Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth Rate (2015-2025) (USD Million)
Figure 33. Canada Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth Rate (2015-2025) (USD Million)
Figure 34. Mexico Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth Rate (2015-2020) (USD Million)
Figure 35. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Country in 2019
Figure 36. Germany Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (2015-2025) (USD Million)
Figure 37. United Kingdom Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (2015-2025) (USD Million)
Figure 38. France Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (2015-2025) (USD Million)
Figure 39. Russia Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (2015-2025) (USD Million)
Figure 40. Italy Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (2015-2025) (USD Million)
Figure 41. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Region 2018
Figure 42. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Region 2018
Figure 43. China Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (2015-2025) (USD Million)
Figure 44. Japan Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (2015-2025) (USD Million)
Figure 45. Korea Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (2015-2025) (USD Million)
Figure 46. India Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (2015-2025) (USD Million)
Figure 47. Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (2015-2025) (USD Million)
Figure 48. Australia Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (2015-2025) (USD Million)
Figure 49. South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Country in 2019
Figure 50. South America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Country in 2019
Figure 51. Brazil Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (2015-2025) (USD Million)
Figure 52. Argentina Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (2015-2025) (USD Million)
Figure 53. Saudi Arabia Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (2015-2025) (USD Million)
Figure 54. Turkey Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (2015-2025) (USD Million)
Figure 55. Egypt Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (2015-2025) (USD Million)
Figure 56. South Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (2015-2025) (USD Million)
Figure 57. Global Revenue Market Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Type in 2019
Figure 58. Global Revenue Market Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Application in 2019
Figure 59. Sales Channel: Direct Channel vs Indirect Channel
Please feel free to write an email to us or to use our electronic ticketing system.
